Jundishapur Journal of Microbiology

Published by: Kowsar

Pseudomonas aeruginosa Recombinant Flagellin Induced Poly-Isotypic Humoral Immune Responses in the Balb/C Mice

Arezoo Shajiei 1 , 2 , Arezoo Rezaei Malal 3 , Ghorbanali Shahabi 3 , Ramin Farhoudi 4 , Sobhan Faezi 5 , Majid Tebianian 6 , Nooshin Sohrabi 7 and Mehdi Mahdavi 1 , *
Authors Information
1 Department of Virology, Pasteur Institute of Iran, Tehran, IR Iran
2 Molecular Pathology Laboratory, Ghaem Medical Center, Mashhad University of Medical sciences, Mashhad, IR Iran
3 Department of Immunology, Cellular and Molecular Research Center, Shahrekord University, Shahrekord, IR Iran
4 Department of Laboratory Animal Science, Pasteur Institute of Iran, Tehran, IR Iran
5 Department of Bacteriology, Pasteur Institute of Iran, Tehran, IR Iran
6 Department of Biotechnology, Razi Vaccine and Serum Research Institute, Karaj, IR Iran
7 Department of Biology, Payam Noor University, Pardis, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: September 01, 2013, 6 (7); e6760
  • Published Online: September 10, 2013
  • Article Type: Research Article
  • Received: June 11, 2012
  • Revised: September 19, 2012
  • Accepted: October 24, 2012
  • DOI: 10.5812/jjm.6760

To Cite: Shajiei A, Rezaei Malal A, Shahabi G, Farhoudi R, Faezi S, et al. Pseudomonas aeruginosa Recombinant Flagellin Induced Poly-Isotypic Humoral Immune Responses in the Balb/C Mice, Jundishapur J Microbiol. 2013 ; 6(7):e6760. doi: 10.5812/jjm.6760.

Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Pier G. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections. Expert Rev Vaccines. 2005; 4(5): 645-56[DOI][PubMed]
  • 2. Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns. 2004; 30(4): 357-61[DOI][PubMed]
  • 3. Ramos HC, Rumbo M, Sirard JC. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004; 12(11): 509-17[DOI][PubMed]
  • 4. Winstanley C, Coulson MA, Wepner B, Morgan JA, Hart CA. Flagellin gene and protein variation amongst clinical isolates of Pseudomonas aeruginosa. Microbiology. 1996; 142 ( Pt 8): 2145-51[PubMed]
  • 5. McSorley SJ, Ehst BD, Yu Y, Gewirtz AT. Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo. J Immunol. 2002; 169(7): 3914-9[PubMed]
  • 6. Sanders CJ, Yu Y, Moore DA, 3rd, Williams IR, Gewirtz AT. Humoral immune response to flagellin requires T cells and activation of innate immunity. J Immunol. 2006; 177(5): 2810-8[PubMed]
  • 7. Higgins SC, Mills KH. TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants. Curr Infect Dis Rep. 2010; 12(1): 4-12[DOI][PubMed]
  • 8. Munster AndrewM, Leary AnneG. Cell-mediated immune responses to pseudomonas aeruginosa. Am J Surg. 1977; 133(6): 710-2[DOI]
  • 9. Cripps AW, Dunkley ML, Clancy RL, Kyd J. Pulmonary immunity to Pseudomonas aeruginosa. Immunol Cell Biol. 1995; 73(5): 418-24[DOI][PubMed]
  • 10. Johansen HK, Hougen HP, Rygaard J, Hoiby N. Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats. Clin Exp Immunol. 1996; 103(2): 212-8[PubMed]
  • 11. Honko AN, Sriranganathan N, Lees CJ, Mizel SB. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun. 2006; 74(2): 1113-20[DOI][PubMed]
  • 12. Singh M, O'Hagan DT. Recent advances in vaccine adjuvants. Pharm Res. 2002; 19(6): 715-28[PubMed]
  • 13. Mahdavi M, Ebtekar M, Khorram Khorshid HR, Azadmanesh K, Hartoonian C, Hassan ZM. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses. Immunol Lett. 2011; 140(1-2): 14-20[DOI][PubMed]
  • 14. Campodonico VL, Llosa NJ, Grout M, Doring G, Maira-Litran T, Pier GB. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Infect Immun. 2010; 78(2): 746-55[DOI][PubMed]
  • 15. Doring G, Pier GB. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine. 2008; 26(8): 1011-24[DOI][PubMed]
  • 16. Goudarzi G, Sattari M, Roudkenar MH, Montajabi-Niyat M, Zavaran-Hosseini A, Mosavi-Hosseini K. Cloning, expression, purification, and characterization of recombinant flagellin isolated from Pseudomonas aeruginosa. Biotechnol Lett. 2009; 31(9): 1353-60[DOI][PubMed]
  • 17. Faezi S, Sattari M, Mahdavi M, Roudkenar MH. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis. Burns. 2011; 37(5): 865-72[DOI][PubMed]
  • 18. Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med. 2005; 171(11): 1209-23[DOI][PubMed]
  • 19. Jang SI, Lillehoj HS, Lee SH, Lee KW, Park MS, Bauchan GR, et al. Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection. Vet Parasitol. 2010; 172(3-4): 221-8[DOI][PubMed]
  • 20. Kyd JM, Dunkley ML, Cripps AW. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Infect Immun. 1995; 63(8): 2931-40[PubMed]
  • 21. Saha S, Takeshita F, Matsuda T, Jounai N, Kobiyama K, Matsumoto T, et al. Blocking of the TLR5 activation domain hampers protective potential of flagellin DNA vaccine. J Immunol. 2007; 179(2): 1147-54[PubMed]
  • 22. Jiao XD, Hu YH, Sun L. Dissection and localization of the immunostimulating domain of Edwardsiella tarda FliC. Vaccine. 2010; 28(34): 5635-40[DOI][PubMed]
  • 23. Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SL, et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol. 2003; 4(12): 1247-53[DOI][PubMed]
  • 24. Ben-Yedidia T, Marcus H, Reisner Y, Arnon R. Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection. Int Immunol. 1999; 11(7): 1043-51[PubMed]
  • 25. Honko AN, Mizel SB. Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect Immun. 2004; 72(11): 6676-9[DOI][PubMed]
  • 26. Verma A, Arora SK, Kuravi SK, Ramphal R. Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect Immun. 2005; 73(12): 8237-46[DOI][PubMed]
  • 27. Buret A, Dunkley ML, Pang G, Clancy RL, Cripps AW. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha. Infect Immun. 1994; 62(12): 5335-43[PubMed]
  • 28. Vassilieva EV, Wang BZ, Vzorov AN, Wang L, Wang YC, Bozja J, et al. Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant. MBio. 2011; 2(1)-10[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments